Feasibility of blood testing combined with PET-CT to screen for cancer and guide intervention.
Journal
Science (New York, N.Y.)
ISSN: 1095-9203
Titre abrégé: Science
Pays: United States
ID NLM: 0404511
Informations de publication
Date de publication:
03 07 2020
03 07 2020
Historique:
received:
30
03
2020
accepted:
23
04
2020
pubmed:
30
4
2020
medline:
18
7
2020
entrez:
30
4
2020
Statut:
ppublish
Résumé
Cancer treatments are often more successful when the disease is detected early. We evaluated the feasibility and safety of multicancer blood testing coupled with positron emission tomography-computed tomography (PET-CT) imaging to detect cancer in a prospective, interventional study of 10,006 women not previously known to have cancer. Positive blood tests were independently confirmed by a diagnostic PET-CT, which also localized the cancer. Twenty-six cancers were detected by blood testing. Of these, 15 underwent PET-CT imaging and nine (60%) were surgically excised. Twenty-four additional cancers were detected by standard-of-care screening and 46 by neither approach. One percent of participants underwent PET-CT imaging based on false-positive blood tests, and 0.22% underwent a futile invasive diagnostic procedure. These data demonstrate that multicancer blood testing combined with PET-CT can be safely incorporated into routine clinical care, in some cases leading to surgery with intent to cure.
Identifiants
pubmed: 32345712
pii: science.abb9601
doi: 10.1126/science.abb9601
pmc: PMC7509949
mid: NIHMS1599179
pii:
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : NCI NIH HHS
ID : U01 CA152753
Pays : United States
Organisme : NINDS NIH HHS
ID : R21 NS113016
Pays : United States
Organisme : NCI NIH HHS
ID : HHSN261201600034C
Pays : United States
Organisme : NCI NIH HHS
ID : P50 CA228991
Pays : United States
Organisme : NCI NIH HHS
ID : U01 CA230691
Pays : United States
Organisme : NCI NIH HHS
ID : R44 CA203350
Pays : United States
Organisme : NCI NIH HHS
ID : R37 CA230400
Pays : United States
Organisme : NIGMS NIH HHS
ID : T32 GM007309
Pays : United States
Organisme : NIGMS NIH HHS
ID : T32 GM136577
Pays : United States
Organisme : NCI NIH HHS
ID : P50 CA062924
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA006973
Pays : United States
Commentaires et corrections
Type : CommentIn
Type : CommentIn
Type : CommentIn
Type : CommentIn
Informations de copyright
Copyright © 2020, American Association for the Advancement of Science.
Références
N Engl J Med. 2011 Aug 4;365(5):395-409
pubmed: 21714641
Proc Natl Acad Sci U S A. 2020 Mar 3;117(9):4858-4863
pubmed: 32075918
CA Cancer J Clin. 2020 Jan;70(1):7-30
pubmed: 31912902
J Clin Oncol. 2015 Dec 10;33(35):4176-87
pubmed: 26527776
J Vasc Interv Radiol. 2003 Sep;14(9 Pt 2):S199-202
pubmed: 14514818
Cell. 2016 Jan 14;164(1-2):57-68
pubmed: 26771485
Nucleic Acids Res. 2017 Jan 4;45(D1):D777-D783
pubmed: 27899578
BMC Med Inform Decis Mak. 2012 May 28;12:45
pubmed: 22640398
Nature. 2017 May 4;545(7652):60-65
pubmed: 28397821
Cancer. 1995 May 15;75(10):2507-17
pubmed: 7736395
N Engl J Med. 2018 Feb 1;378(5):449-459
pubmed: 29385376
Crit Rev Oncol Hematol. 2018 Jun;126:64-79
pubmed: 29759569
Nat Rev Clin Oncol. 2018 Jun;15(6):353-365
pubmed: 29599476
Gastroenterology. 2019 May;156(7):2024-2040
pubmed: 30721664
Proc Natl Acad Sci U S A. 2005 Nov 8;102(45):16368-73
pubmed: 16258065
Oncology (Williston Park). 2005 Apr;19(4):481-90; discussion 490-2, 495-6
pubmed: 15934517
Cancer Discov. 2020 May;10(5):664-673
pubmed: 32111602
JAMA. 2016 Jun 21;315(23):2576-94
pubmed: 27305422
Gynecol Oncol. 1996 Jul;62(1):67-72
pubmed: 8690294
Clin Chem. 2015 Jan;61(1):64-71
pubmed: 25421801
Proc Natl Acad Sci U S A. 2017 Jul 11;114(28):7414-7419
pubmed: 28652331
Science. 2018 Feb 23;359(6378):926-930
pubmed: 29348365
Proc Natl Acad Sci U S A. 2011 Jun 7;108(23):9530-5
pubmed: 21586637
Sci Transl Med. 2016 Jul 6;8(346):346ra92
pubmed: 27384348
J Clin Oncol. 2014 Feb 20;32(6):579-86
pubmed: 24449238
N Engl J Med. 2017 Aug 10;377(6):513-522
pubmed: 28792880
Sci Transl Med. 2018 Nov 7;10(466):
pubmed: 30404863
Am J Prev Med. 2019 Aug;57(2):250-255
pubmed: 31248742
J Chronic Dis. 1987;40(5):373-83
pubmed: 3558716
Eur Respir J. 2014 Oct;44(4):1055-68
pubmed: 25142482
NPJ Precis Oncol. 2018 Oct 29;2:23
pubmed: 30393772
J Nucl Med. 2007 Jan;48 Suppl 1:4S-18S
pubmed: 17204716
Prev Chronic Dis. 2018 Jul 26;15:E97
pubmed: 30048233
Ann Oncol. 1994 May;5(5):397-400
pubmed: 8075046
Am J Gastroenterol. 2016 Jan;111(1):105-14
pubmed: 26526080
Oncotarget. 2016 Jul 12;7(28):44695-44704
pubmed: 27213584
Nature. 2019 Jun;570(7761):385-389
pubmed: 31142840
Sci Transl Med. 2019 Aug 28;11(507):
pubmed: 31462507
Ann Intern Med. 2013 Sep 17;159(6):411-420
pubmed: 23897166
Med Decis Making. 2003 Jul-Aug;23(4):281-92
pubmed: 12926578
Sci Transl Med. 2014 Feb 19;6(224):224ra24
pubmed: 24553385
Proc Natl Acad Sci U S A. 2016 Mar 29;113(13):E1826-34
pubmed: 26976580
CA Cancer J Clin. 2017 Mar;67(2):93-99
pubmed: 28094848
Curr Radiol Rep. 2013 May 3;1:177-190
pubmed: 24883234
Oncologist. 2004;9(6):633-43
pubmed: 15561807
Nat Med. 2019 Dec;25(12):1928-1937
pubmed: 31768066
Ann Intern Med. 2011 Nov 15;155(10):698-705, W216
pubmed: 22006929
Nat Rev Cancer. 2019 Jun;19(6):349-358
pubmed: 31024081